LSE creators

Number of items: 4.
European Institute
  • Tzouma, Victoria, Grepstad, Mari, Grimaccia, Federico, Kanavos, Panos (2015). Clinical, ethical, and socioeconomic considerations for prescription drug use during pregnancy in women suffering from chronic diseases. Therapeutic Innovation and Regulatory Science, 49(6), 947-956. https://doi.org/10.1177/2168479015589820
  • Tordrup, David, Tzouma, Victoria, Kanavos, Panos (2014). Orphan drug considerations in Health Technology Assessment ineight European countries. Rare Diseases and Orphan Drugs: An International Journal of Public Health, 1(3), 86-97.
    • Health Policy
  • Kamphuis, Bregtje, Efthymiadou, Olina, Kanavos, Panos, Tzouma, Victoria (2021). Severe asthma care and treatment: indicators and data for performance management across ten countries. LSE Consulting. picture_as_pdf
  • Efthymiadou, Olina, Kamphuis, Bregtje, Kanavos, Panos, Tzouma, Victoria (2021). Treatment gaps in severe asthma across nine OECD countries and recommendations for addressing them: an international survey of clinicians. LSE Consulting. picture_as_pdf
    • LSE Health
  • Tzouma, Victoria, Grepstad, Mari, Grimaccia, Federico, Kanavos, Panos (2015). Clinical, ethical, and socioeconomic considerations for prescription drug use during pregnancy in women suffering from chronic diseases. Therapeutic Innovation and Regulatory Science, 49(6), 947-956. https://doi.org/10.1177/2168479015589820
  • Tordrup, David, Tzouma, Victoria, Kanavos, Panos (2014). Orphan drug considerations in Health Technology Assessment ineight European countries. Rare Diseases and Orphan Drugs: An International Journal of Public Health, 1(3), 86-97.
    • Social Policy
  • Tzouma, Victoria, Grepstad, Mari, Grimaccia, Federico, Kanavos, Panos (2015). Clinical, ethical, and socioeconomic considerations for prescription drug use during pregnancy in women suffering from chronic diseases. Therapeutic Innovation and Regulatory Science, 49(6), 947-956. https://doi.org/10.1177/2168479015589820
  • Tordrup, David, Tzouma, Victoria, Kanavos, Panos (2014). Orphan drug considerations in Health Technology Assessment ineight European countries. Rare Diseases and Orphan Drugs: An International Journal of Public Health, 1(3), 86-97.